These results indicate that TET2 expression in tumor cells is important for the activation of tumor-infiltrated T cells to produce IFN-γ, leading to responses in tumor cells and other cells of the tumor microenvironment that are robustly induced with VC treatment. The gene discussed is IFNG; the disease is neoplasm.